EUVIMEDEUVIMED entdecken
Crossref

Dose-dependent association between proton pump inhibitor use and the risk of migraine: a nationwide matched case–control study

Yuan-Zhen Ruan, Fu-Chi Yang, Ya-Mei Bai, Chia-Fen Tsai, Chih-Sung Liang, Tung-Ping Su, Shih-Jen Tsai, Tzeng-Ji Chen, Chia-Kuang Tsai iD, Mu-Hong Chen

Postgraduate Medical Journal · 2025

DOI: 10.1093/postmj/qgaf077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Postgraduate Medical Journal, 2025. Verfasst von Yuan-Zhen Ruan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec. 2, Chenggong Rd., Neihu District, Taipei City 1…. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Migraine Disorders, Myocardial Infarction, Exercise. Die Arbeit nennt 35 Literaturangaben. Gefördert von: National Science and Technology Council, Ministry of Science and Technology, Ministry of National Defense Medical Affairs Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Proton pump inhibitors (PPIs) are widely prescribed, but their link to migraine risk, especially in Asian populations, remains unclear. This longitudinal study aimed to answer the following question: Does PPI exposure show a dose-dependent risk of migraine, varying by subtype and PPI indication in an Asian population?

Method

Using Taiwan’s National Health Insurance Research Database (2000–15), we conducted a matched case–control study on PPI exposure. Adults prescribed PPIs for peptic ulcers, gastroesophageal reflux disease, or upper gastrointestinal bleeding were included, excluding those with prior migraines or incomplete data. Controls were matched 1:1 by age, sex, and residence. PPI exposure was measured in cumulative defined daily doses (cDDDs).

Result

The study included 22 834 PPI users (11 417 cases, 11 417 controls) with a mean follow-up of 4.1 ± 3.3 years. The study population comprised 65.6% females and 34.4% males, with no significant sex difference (P = 1.000). Mean age was 47.27 ± 15.16 years in cases and 47.42 ± 15.14 years in controls (P = .444). The average interval from PPI initiation to migraine diagnosis was 2.4 ± 1.9 years. Compared with those with the lowest PPI exposure (cDDD ≤30), migraine risk progressively increases with greater cumulative exposure: cDDD 31–120 [aOR = 1.22, 95% confidence interval (CI) = 1.15–1.30], cDDD 121–365 (aOR = 1.42, 95% CI = 1.32–1.52), and cDDD >365 (aOR = 1.60, 95% CI = 1.41–1.80). This dose-dependent relationship was consistent across migraine subtypes and PPI indications.

Conclusion

This large-scale Asian population study revealed a significant dose-dependent association between PPI exposure and increased migraine risk, emphasizing the need for cautious prescribing and monitoring of migraine symptoms in long-term PPI users, particularly in Asian populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsMigraine DisordersMyocardial InfarctionExerciseHumansMaleFemaleMiddle AgedTaiwanCase-Control StudiesAdultMendelian Randomization AnalysisBayes TheoremLongitudinal StudiesRisk Factors

Stichwörter der Autor:innen

Asian populationcase–control studymigrainepharmacoepidemiologyproton pump inhibitors

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec. 2, Chenggong Rd., Neihu District, Taipei City 114202, Taiwan.
  • Department of Psychiatry, Taipei Veterans General Hospital, No. 201, Sec. Shihpai Road, Beitou District, Taipei 11217, Taiwan.
  • Department of Psychiatry, College of Medicine, National Yang Ming Chiao Tung University, No. 155, Sec. 2, Linong St. Beitou Dist., Taipei City 112304, Taiwan.
  • Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, National Defense Medical Center, No. 60, Xinmin Rd., Beitou Dist., Taipei City 112003, Taiwan.
  • Department of Psychiatry, National Defense Medical Center, No. 161, Sec. 6, Minquan E. Rd., Neihu Dist., Taipei City 11490, Taiwan.
  • Department of Psychiatry, General Cheng Hsin Hospital, No. 45, Cheng Hsin St., Beitou Dist., Taipei City 11220, Taiwan.

ORCID-Profile: Chia-Kuang Tsai

Förderung

  • National Science and Technology Council
  • Ministry of Science and Technology
  • Ministry of National Defense Medical Affairs Bureau
  • Tri-Service General Hospital
  • Tjing Ling Medical Foundation
  • Taipei Veterans General Hospital

Zitieren

APA

Ruan, Y. Z., Yang, F. C., Bai, Y. M., Tsai, C. F., Liang, C. S., Su, T. P., Tsai, S. J., Chen, T. J., Tsai, C. K., & Chen, M. H. (2025). Dose-dependent association between proton pump inhibitor use and the risk of migraine: a nationwide matched case–control study. Postgraduate Medical Journal. https://doi.org/10.1093/postmj/qgaf077

Vancouver

Ruan YZ, Yang FC, Bai YM, Tsai CF, Liang CS, Su TP, et al. Dose-dependent association between proton pump inhibitor use and the risk of migraine: a nationwide matched case–control study. Postgraduate Medical Journal. 2025. doi:10.1093/postmj/qgaf077

BibTeX
@article{Ruan2025,
  author = {Ruan, Yuan-Zhen and Yang, Fu-Chi and Bai, Ya-Mei and Tsai, Chia-Fen and Liang, Chih-Sung and Su, Tung-Ping and Tsai, Shih-Jen and Chen, Tzeng-Ji and Tsai, Chia-Kuang and Chen, Mu-Hong},
  title = {Dose-dependent association between proton pump inhibitor use and the risk of migraine: a nationwide matched case–control study},
  journal = {Postgraduate Medical Journal},
  year = {2025},
  doi = {10.1093/postmj/qgaf077}
}
Kostenlos starten →